IUSDF (As One) 3-Year ROIIC % : 25.31% (As of Mar. 2026) — 73% Above Median


IUSDF As One Corp IUSDF
84 GF Score
Price $14.00
GF Value $18.84
View Full Analysis

What is As One 3-Year ROIIC %?

As One IUSDF 84 3-Year ROIIC % is 25.31 as of Mar. 2026, which is 73% above its 10-year median of 14.67. GuruFocus rates IUSDF with a GF Score™ of 84/100 and a GF Value™ of $18.84. Among 113 Medical Distribution companies, As One ranks better than 88.5% on this metric.

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. As One's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 25.31%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for As One's 3-Year ROIIC % or its related term are showing as below:

IUSDF's 3-Year ROIIC % is ranked better than
88.5% of 113 companies
in the Medical Distribution industry
Industry Median: 2.2 vs IUSDF: 25.31

As One  (OTCPK:IUSDF) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


As One 3-Year ROIIC % Related Terms


As One 3-Year ROIIC % Historical Data

* Premium members only.

The historical data trend for As One's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

As One 3-Year ROIIC % Chart

As One Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
3-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.31 26.49 11.73 151.43 25.31

As One Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 151.43 0.00 0.00 0.00 25.31

IUSDF vs MCK, CAH, COR: 3-Year ROIIC % Comparison

For the Medical Distribution subindustry, As One's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


As One 3-Year ROIIC % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, As One's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where As One's 3-Year ROIIC % falls into.


IUSDF
84GF Score
As One Corp IUSDF
3-Year ROIIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

As One 3-Year ROIIC % Calculation

As One's 3-Year ROIIC % for the quarter that ended in Mar. 2026 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 56.3334552 (Mar. 2026) - 59.2819733 (Mar. 2023) )/( 384.232 (Mar. 2026) - 426.136 (Mar. 2023) )
=-2.9485181/-41.904
=7.04%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Frequently Asked Questions Learn more about 3-Year ROIIC % →
What does a 3-Year ROIIC % of 25.31 mean?
As One (IUSDF) has a 3-Year ROIIC % of 25.31 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on As One and its competitors. This is 73% above median its historical median of 14.67. Over the past decade, As One's 3-Year ROIIC % has ranged from 6.41 to 151.43. According to the industry distribution chart, As One ranks #13 out of 113 companies in the Medical Distribution industry, placing it in the top 11.5%.
Is As One's 3-Year ROIIC % too high?
As One's current 3-Year ROIIC % of 25.31 is 73% above median its 10-year median of 14.67. Over the past 10 years, this metric has ranged from a low of 6.41 to a high of 151.43. The Medical Distribution industry median 3-Year ROIIC % is 2.20. As One's value of 25.31 is 1050.5% above this industry median. Based on the distribution chart, As One ranks #13 out of 113 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, As One has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does As One's 3-Year ROIIC % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, As One ranks #13 out of 113 companies for 3-Year ROIIC %. This places As One in the top 12% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 2.20. As One's value of 25.31 is 1050.5% above this benchmark. Historically, As One's own 3-Year ROIIC % has ranged from 6.41 to 151.43 over the past decade. While the company's 10-year median is 14.67 vs. the industry median of 2.20, As One has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.20, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. As One's current 3-Year ROIIC % of 25.31 is 1050.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on As One and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. As One's current 3-Year ROIIC % is 25.31, which is 73% above median its own 10-year median of 14.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is As One stock overvalued right now?
As One (IUSDF) has a current 3-Year ROIIC % of 25.31. The stock's GF Value™ is $18.84, compared to a current price of $14.00 — trading 25.7% below its estimated fair value. The current 3-Year ROIIC % is 25.31, which is 73% above median its 10-year median of 14.67 and 1050.5% above the Medical Distribution industry median of 2.20. As One's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For As One (IUSDF), the current 3-Year ROIIC % is 25.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is As One (IUSDF) Overvalued in 2026?

Based on GuruFocus' analysis, As One stock appears to be undervalued. The current stock price of $14.00 is trading 25.7% below its estimated GF Value™ of $18.84.

Key valuation signals for IUSDF:

  • 3-Year ROIIC %: 25.31 (73% above median its 10-year median of 14.67)
  • GF Value™: $18.84 vs. price of $14.00 (25.7% below fair value)
  • GF Score™: 84/100
  • Industry Position: 1050.5% above the Medical Distribution median (#13 of 113)

No single metric tells the full story. See the IUSDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


As One Business Description

Other Exchanges 7476:Japan
Address Edobori 2-1-27 Nishi-ku, Osaka, JPN
As One Corp is a trading engaged in sale of scientific instruments, industrial instruments, hospital or nursing instruments and approach to specialized fields. The company generates maximum revenue from scientific instrument product line which includes measuring instruments; cultivation, separation, analysis products such as microscopes, glass slides, and tissue culture products; Equipment / storage / conveyance products such as experimental platforms, fume hoods; Vessels or containers which includes storage of samples, reagents; Necessities for experiments including glass or plastic beakers, flask indispensable for experiments, hoses, tubes, joints, plus paper products such as tapes and labels; Equipment for laboratories like timers, packaging machines, tools, office supplies.
84GF Score

Get the complete analysis for IUSDF

3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.00
Price
$18.84
GF Value